Results 91 to 100 of about 21,016 (175)

Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms

, 2015
Inês Santos Ferreira,1 Ana F Bettencourt,1 Lídia MD Gonçalves,1 Stefanie Kasper,2 Bertrand Bétrisey,3 Judith Kikhney,2 Annette Moter,2 Andrej Trampuz,4 António J Almeida1 1Research Institute for Medicines (iMed.ULisboa),
Almeida AJ, Trampuz A, Kasper S, Kikhney J, Santos Ferreira I, Gonçalves LMD, Moter A, Bettencourt AF, Bétrisey B   +8 more
core  

Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution

, 2019
Therapeutic drug monitoring (TDM) could optimise daptomycin use. However, no validated serum target levels have been established. This prospective study at a tertiary centre including hospitalised patients receiving daptomycin aimed to evaluate the ...
Bouza Santiago, Emilio, Sánchez-Somolinos, Mar, Verde, Eduardo, Juárez, Miriam, Cercenado Mansilla, Emilia, Valerio Minero, Maricela, Muñoz García, Patricia Carmen, Galar, Alicia, Burillo Albizua, Almudena, García González, Xandra   +9 more
core   +1 more source

Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.

PLoS ONE
BackgroundIn the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs), vancomycin stands as the prevalent therapeutic agent.
Yau Adamu, Mireia Puig-Asensio, Bashir Dabo, Marin L Schweizer   +3 more
doaj   +1 more source

Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study

Annals of Clinical Microbiology and Antimicrobials, 2017
Background Daptomycin has been reported to cause artificial prolongation of prothrombin time (PT) by interacting with some test reagents of PT. This prolongation was particularly prominent with high concentrations of daptomycin in vitro. However, whether
Makoto Saito, Shuji Hatakeyama, Hideki Hashimoto, Takumitsu Suzuki, Daisuke Jubishi, Makoto Kaneko, Yukio Kume, Takehito Yamamoto, Hiroshi Suzuki, Hiroshi Yotsuyanagi   +9 more
doaj   +1 more source

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure

, 2013
Kaori Yabuno,1,2,* Masafumi Seki,1,* Koji Miyawaki,1,2 Yoshihiro Miwa,2 Kazunori Tomono11Division of Infection Control and Prevention, 2Department of Pharmacy, Osaka University Hospital, Osaka, Japan *These authors contributed equally to this ...
Yabuno K, Miyawaki K, Miwa Y, Seki M, Tomono K   +4 more
core  

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

, 2016
Armando Gonzalez-Ruiz,1 R Andrew Seaton,2 Kamal Hamed3 1Darent Valley Hospital, Dartford, UK; 2Queen Elizabeth University Hospital, Glasgow, UK; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Abstract: Infections caused by Gram-positive ...
Hamed K, Gonzalez-Ruiz A, Seaton RA
core  

Safety of high-dose daptomycin in patients with severe renal impairment

, 2018
Chih-Hsun Tai,1 Chi-Hao Shao,2 Chen-You Chen,2 Shu-Wen Lin,1–3 Chien-Chih Wu1,2 1Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan; 2School of Pharmacy, College of Medicine,
Chen CY, Shao CH, Tai CH, Lin SW, Wu CC
core  

Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case-control study [PDF]

, 2014
Vancomycin is the standard antibiotic for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. While daptomycin is approved for MRSA bacteremia, its effectiveness in osteoarticular infections (OAIs) has not been established.
Babcock, Hilary M, Khair, Hani N, Liang, Stephen Y, Marschall, Jonas, McDonald, Jay R   +4 more
core   +2 more sources

Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery

Case Reports in Pulmonology, 2017
Background. Daptomycin is a cyclic lipopeptide antibiotic that provides great coverage for gram positive cocci. From the early years of daptomycin use, concerns were raised regarding the pulmonary side effects of daptomycin and potential development of ...
Mohamad Rachid, Khansa Ahmad, Meghan Saunders-Kurban, Aelia Fatima, Aditya Shah, Anas Nahhas   +5 more
doaj   +1 more source

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis

, 2016
Chao Liu,1,* Zhi Mao,1,* Mengmeng Yang,1 Hongjun Kang,1 Hui Liu,1 Liang Pan,1 Jie Hu,1 Jun Luo,2 Feihu Zhou1 1Department of Surgical Intensive Care Unit, Chinese People’s Liberation Army General Hospital, Beijing, 2Department of Surgical Intensive
Liu H, Yang MM, Zhou FH, Kang HJ, Hu J, Luo J, Liu C, Pan L, Mao Z   +8 more
core